$GKOS
GLAUKOS Corp

2021 Q1 Form 10-Q Financial Statement

#000155837021006261 Filed on May 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $67.97M $55.34M
YoY Change 22.83% 2.42%
Cost Of Revenue $16.63M $32.53M
YoY Change -48.87% 357.45%
Gross Profit $51.34M $22.81M
YoY Change 125.08% -51.39%
Gross Profit Margin 75.53% 41.22%
Selling, General & Admin $41.92M $50.55M
YoY Change -17.06% 44.73%
% of Gross Profit 81.66% 221.62%
Research & Development $21.22M $24.87M
YoY Change -14.69% 78.56%
% of Gross Profit 41.33% 109.06%
Depreciation & Amortization $1.150M $1.082M
YoY Change 6.28% 28.5%
% of Gross Profit 2.24% 4.74%
Operating Expenses $63.14M $75.42M
YoY Change -16.28% 54.37%
Operating Profit -$11.81M -$52.61M
YoY Change -77.56% 2611.96%
Interest Expense $3.229M -$2.190M
YoY Change -247.44% -417.39%
% of Operating Profit
Other Income/Expense, Net -$4.385M -$1.896M
YoY Change 131.28% -363.33%
Pretax Income -$16.19M -$54.51M
YoY Change -70.3% 4367.87%
Income Tax $279.0K -$450.0K
% Of Pretax Income
Net Earnings -$16.47M -$54.06M
YoY Change -69.53% 3928.17%
Net Earnings / Revenue -24.23% -97.69%
Basic Earnings Per Share -$0.36 -$1.24
Diluted Earnings Per Share -$0.36 -$1.24
COMMON SHARES
Basic Shares Outstanding 45.71M 43.74M
Diluted Shares Outstanding 45.71M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $407.4M $163.7M
YoY Change 148.87% 12.66%
Cash & Equivalents $96.63M $53.61M
Short-Term Investments $310.8M $110.1M
Other Short-Term Assets $15.00M $11.10M
YoY Change 35.14% 152.27%
Inventory $15.27M $27.70M
Prepaid Expenses
Receivables $36.69M $28.89M
Other Receivables $0.00 $0.00
Total Short-Term Assets $474.3M $231.4M
YoY Change 104.98% 25.96%
LONG-TERM ASSETS
Property, Plant & Equipment $43.31M $22.76M
YoY Change 90.31% -29.54%
Goodwill $66.13M $66.13M
YoY Change 0.0%
Intangibles $351.5M $376.4M
YoY Change -6.62%
Long-Term Investments
YoY Change
Other Assets $17.00M $14.60M
YoY Change 16.44% 21.67%
Total Long-Term Assets $548.5M $548.3M
YoY Change 0.03% 1137.77%
TOTAL ASSETS
Total Short-Term Assets $474.3M $231.4M
Total Long-Term Assets $548.5M $548.3M
Total Assets $1.023B $779.7M
YoY Change 31.17% 241.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.624M $12.94M
YoY Change -33.37% 127.07%
Accrued Expenses $47.94M $38.13M
YoY Change 25.73% 75.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $279.0M
YoY Change
Total Short-Term Liabilities $335.6M $51.08M
YoY Change 556.98% 87.1%
LONG-TERM LIABILITIES
Long-Term Debt $61.10M $59.30M
YoY Change 3.04%
Other Long-Term Liabilities $7.598M $4.491M
YoY Change 69.18% -70.45%
Total Long-Term Liabilities $7.598M $4.491M
YoY Change 69.18% -70.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $335.6M $51.08M
Total Long-Term Liabilities $7.598M $4.491M
Total Liabilities $433.0M $138.4M
YoY Change 212.82% 225.7%
SHAREHOLDERS EQUITY
Retained Earnings -$332.1M -$243.8M
YoY Change 36.23%
Common Stock $920.9M $883.2M
YoY Change 4.27%
Preferred Stock
YoY Change
Treasury Stock (at cost) $132.0K $132.0K
YoY Change 0.0%
Treasury Stock Shares $28.00K $28.00K
Shareholders Equity $589.8M $641.3M
YoY Change
Total Liabilities & Shareholders Equity $1.023B $779.7M
YoY Change 31.17% 241.98%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$16.47M -$54.06M
YoY Change -69.53% 3928.17%
Depreciation, Depletion And Amortization $1.150M $1.082M
YoY Change 6.28% 28.5%
Cash From Operating Activities $4.178M -$13.10M
YoY Change -131.9% -6397.6%
INVESTING ACTIVITIES
Capital Expenditures $17.18M $782.0K
YoY Change 2097.19% 20.12%
Acquisitions
YoY Change
Other Investing Activities -$4.080M $1.410M
YoY Change -389.36% -233.02%
Cash From Investing Activities -$21.26M $628.0K
YoY Change -3485.83% -136.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 17.41M 4.220M
YoY Change 312.65% -21.95%
NET CHANGE
Cash From Operating Activities 4.178M -13.10M
Cash From Investing Activities -21.26M 628.0K
Cash From Financing Activities 17.41M 4.220M
Net Change In Cash -121.0K -8.816M
YoY Change -98.63% -326.23%
FREE CASH FLOW
Cash From Operating Activities $4.178M -$13.10M
Capital Expenditures $17.18M $782.0K
Free Cash Flow -$13.00M -$13.88M
YoY Change -6.32% 3033.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
GLAUKOS Corp
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001192448
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021Q1 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-37463
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0945406
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
229 Avenida Fabricante
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Clemente
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92672
CY2021Q1 dei City Area Code
CityAreaCode
949
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
367-9600
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2021Q1 dei Trading Symbol
TradingSymbol
GKOS
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46281586
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96625000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96596000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
310755000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
307772000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36694000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36059000
CY2021Q1 us-gaap Inventory Net
InventoryNet
15271000
CY2020Q4 us-gaap Inventory Net
InventoryNet
15809000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14954000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13206000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
474299000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
469442000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9416000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9566000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43314000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24008000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19720000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20009000
CY2021Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
50838000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
51443000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
351465000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
357693000
CY2021Q1 us-gaap Goodwill
Goodwill
66134000
CY2020Q4 us-gaap Goodwill
Goodwill
66134000
CY2021Q1 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
7591000
CY2020Q4 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
7207000
CY2021Q1 us-gaap Assets
Assets
1022777000
CY2020Q4 us-gaap Assets
Assets
1005502000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8624000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4371000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
47944000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45331000
CY2021Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
278996000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
335564000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49702000
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
189416000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20450000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20704000
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
61068000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
60690000
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8323000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10512000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7598000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7029000
CY2021Q1 us-gaap Liabilities
Liabilities
433003000
CY2020Q4 us-gaap Liabilities
Liabilities
338053000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46016000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45275000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45988000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45247000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
46000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
45000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
920819000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
976590000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1128000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1004000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-332087000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-310058000
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
589774000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
667449000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1022777000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1005502000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67968000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55336000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16633000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32529000
CY2021Q1 us-gaap Gross Profit
GrossProfit
51335000
CY2020Q1 us-gaap Gross Profit
GrossProfit
22807000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41921000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
50546000
CY2021Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
21219000
CY2020Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
24873000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
63140000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
75419000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11805000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-52612000
CY2021Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
383000
CY2020Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
696000
CY2021Q1 gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-3229000
CY2020Q1 gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-881000
CY2021Q1 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-1539000
CY2020Q1 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-1711000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4385000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1896000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16190000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54508000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
279000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-450000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-16469000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-54058000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.24
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45709000
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43766000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-16469000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-54058000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
541000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1169000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-417000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-480000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
124000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
689000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16345000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53369000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
667449000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
17035000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8748000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
124000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-16469000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
589774000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6228000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
673272000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
4220000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17176000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
689000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-54058000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
641299000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-16469000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-54058000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1150000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1082000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6228000
CY2021Q1 gkos Amortization Operating Lease Right Of Use Asset
AmortizationOperatingLeaseRightOfUseAsset
1170000
CY2020Q1 gkos Amortization Operating Lease Right Of Use Asset
AmortizationOperatingLeaseRightOfUseAsset
1311000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
343000
CY2021Q1 gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-24000
CY2020Q1 gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-709000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8748000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
17176000
CY2020Q1 gkos Stock Option Plan Expenses
StockOptionPlanExpenses
-3171000
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1101000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2024000
CY2021Q1 gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
256000
CY2020Q1 gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
-19000
CY2021Q1 gkos Increase Decrease In Others Accrued Liabilities
IncreaseDecreaseInOthersAccruedLiabilities
570000
CY2020Q1 gkos Increase Decrease In Others Accrued Liabilities
IncreaseDecreaseInOthersAccruedLiabilities
207000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
547000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9246000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-403000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14568000
CY2021Q1 gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-1803000
CY2020Q1 gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-2235000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3023000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4750000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-29000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4178000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13099000
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
54007000
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
18680000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
50349000
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
19676000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17414000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21263000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
628000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4220000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17182000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
782000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16552000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4454000
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1549000
CY2020Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1278000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1065000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1512000
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
251000
CY2021Q1 gkos Proceeds From Tenant Allowance
ProceedsFromTenantAllowance
629000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71756000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106041000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62940000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-35000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
250000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-450000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-565000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-121000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8816000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106162000
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates and assumptions. Management considers many factors in selecting appropriate financial accounting policies and controls and in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the accompanying condensed consolidated financial statements relate to revenue recognition, the fair value of the liability component of the Convertible Notes, the incremental borrowing rate related to the Company’s leased assets, stock-based compensation expense and the valuation of certain intangible assets related to the Company’s acquisition of Avedro. Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, this process may result in actual results differing materially from those estimated amounts used in the preparation of the condensed consolidated financial statements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company’s condensed consolidated financial statements as of and for the three months ended March 31, 2021 reflect the Company’s estimates of the impact of the ongoing COVID-19 pandemic. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company’s business, results of operations and financial condition, including sales, expenses, reserves and allowances, manufacturing, clinical trials, research and development costs and employee-related amounts, will depend on future developments that are uncertain, including the duration and severity of the COVID-19 outbreak, the severity and transmission rates of new variants of COVID-19, and the actions taken to contain it or treat COVID-19, including the availability, distribution, rate of public acceptance and efficacy of vaccines for COVID-19<span style="color:#0000ff;">, </span>as well as the economic impact on local, regional, national and international customers and markets. As a result, there may be changes to the Company’s estimates regarding the impact of COVID-19 in future periods.</p>
CY2021Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
38161000
CY2020Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
37729000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1467000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96625000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96596000
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
9416000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
9566000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106041000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106162000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
310415000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
482000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
142000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
310755000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
307014000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
765000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
307772000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1670000
CY2021Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
36694000
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
36059000
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6662000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5346000
CY2021Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
3761000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3584000
CY2021Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
4848000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6879000
CY2021Q1 us-gaap Inventory Gross
InventoryGross
15271000
CY2020Q4 us-gaap Inventory Gross
InventoryGross
15809000
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4669000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
10815000
CY2021Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
4175000
CY2020Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3728000
CY2021Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
7568000
CY2020Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
3198000
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
31532000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
27590000
CY2021Q1 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
47944000
CY2020Q4 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
45331000
CY2020Q1 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
CY2021Q1 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
CY2021Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2021Q1 gkos Lessee Operating Lease Period For Lease Termination
LesseeOperatingLeasePeriodForLeaseTermination
P1Y
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2001000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2953000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2555000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1465000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2408000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
5184000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2444000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
5340000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2498000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
5500000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
20790000
CY2021Q1 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
107522000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
35649000
CY2021Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
125011000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13926000
CY2021Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
63943000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
21723000
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
61068000
CY2021Q1 gkos Lessee Operating Lease Option To Extend Value
LesseeOperatingLeaseOptionToExtendValue
12200000
CY2021Q1 gkos Lessee Financing Lease Option To Extend Value
LesseeFinancingLeaseOptionToExtendValue
75800000
CY2021Q1 us-gaap Lessee Operating Lease Lease Not Yet Commenced Existence Of Option To Extend
LesseeOperatingLeaseLeaseNotYetCommencedExistenceOfOptionToExtend
true
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
33735000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
232565000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27507000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
238793000
CY2021Q1 us-gaap Goodwill
Goodwill
66134000
CY2021Q1 us-gaap Goodwill
Goodwill
66134000
CY2020Q4 us-gaap Goodwill
Goodwill
66134000
CY2020Q4 us-gaap Goodwill
Goodwill
66134000
CY2021Q1 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
33735000
CY2021Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
417599000
CY2020Q4 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27507000
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
423827000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
18684000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
24912000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24912000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
24618000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
22092000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
117347000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
232565000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67968000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55336000
CY2021Q1 gkos Period For Payment On Invoice Terms
PeriodForPaymentOnInvoiceTerms
P30D
CY2021Q1 us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2021Q1 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9436000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4804000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 gkos Number Of Votes Per Common Share
NumberOfVotesPerCommonShare
1
CY2020Q4 gkos Number Of Votes Per Common Share
NumberOfVotesPerCommonShare
1
CY2021Q1 gkos Share Based Compensation Number Of Plans
ShareBasedCompensationNumberOfPlans
4
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2021Q1 gkos Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Percentage On First Anniversary Date Of Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPercentageOnFirstAnniversaryDateOfGrant
0.25
CY2021Q1 gkos Share Based Compensation Arrangement By Share Based Payment Award Award Remaining Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod
P3Y
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8748000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14005000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14000000.0
CY2020Q1 gkos Share Based Compensation Arrangement By Share Based Payment Award Options Fair Value Adjustment
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueAdjustment
-3200000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
50900000
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0088
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-500000
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23500000
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17800000
CY2021Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
8800000
CY2021Q1 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2020Q4 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2021Q1 gkos Number Of Months Of Lease Term For Adjustments Of Letters Of Credit Balance Outstanding To Begin
NumberOfMonthsOfLeaseTermForAdjustmentsOfLettersOfCreditBalanceOutstandingToBegin
37
CY2021Q1 gkos Frequency Of Adjustments Of Letters Of Credit Balance Outstanding
FrequencyOfAdjustmentsOfLettersOfCreditBalanceOutstanding
P12M
CY2021Q1 gkos Adjustment Percentage Of Letters Of Credit Balance Outstanding
AdjustmentPercentageOfLettersOfCreditBalanceOutstanding
0.20
CY2021Q1 gkos Minimal Amount Of Letters Of Credit Balance Outstanding After Adjustments
MinimalAmountOfLettersOfCreditBalanceOutstandingAfterAdjustments
2000000.0
CY2021Q1 gkos Number Of Other Irrevocable Letters Of Credit Outstanding
NumberOfOtherIrrevocableLettersOfCreditOutstanding
1
CY2021Q1 gkos Restricted Cash Pledged For Office Lease Agreement
RestrictedCashPledgedForOfficeLeaseAgreement
600000
CY2021Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5700000
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5200000
CY2021Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
5800000
CY2020Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
5300000
CY2021Q1 gkos Other Commitment Obligation Amount
OtherCommitmentObligationAmount
1300000
CY2021Q1 gkos Number Of Business Activities
NumberOfBusinessActivities
1
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001558370-21-006261-index-headers.html Edgar Link pending
0001558370-21-006261-index.html Edgar Link pending
0001558370-21-006261.txt Edgar Link pending
0001558370-21-006261-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gkos-20210331.xsd Edgar Link pending
gkos-20210331x10q.htm Edgar Link pending
gkos-20210331x10q_htm.xml Edgar Link completed
gkos-20210331xex31d1.htm Edgar Link pending
gkos-20210331xex31d2.htm Edgar Link pending
gkos-20210331xex32d1.htm Edgar Link pending
gkos-20210331xex32d2.htm Edgar Link pending
gkos-20210331_cal.xml Edgar Link unprocessable
gkos-20210331_def.xml Edgar Link unprocessable
gkos-20210331_lab.xml Edgar Link unprocessable
gkos-20210331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending